Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,941-20,952 of 23,847
Behavioral study icon
TerminatedNCT05161546

Bipolarity and Retinal Electrophysiological Markers

This study exists to compare options and see whether the medication Bipolar offers something meaningfully different. Researchers are trying to understand whether the medication Bipolar can improve attention, thinking, or day-to-day functioning.

In Laxou
BipolarityBehavioralOver 18 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Bipolarity
Other study type icon
CompletedNCT01849432

Brain Circuitry in Anxiety Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont
Anxiety, PTSDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Anxiety, PTSD
Drug study icon
CompletedNCT04306146

CAD-9303 in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Long Beach
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Cadent Therapeutics
Condition
Schizophrenia
Other study type icon
CompletedNCT03393390

Cognition and Control in Youths

This study exists to compare options and see whether the medication Cognition offers something meaningfully different. Researchers are trying to understand whether the medication Cognition can improve attention, thinking, or day-to-day functioning.

In Ann Arbor
ADHDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 6 Years to 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
ADHD
Drug study icon
CompletedNCT00861796

CYR-101 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toul
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France
Sponsor
Cyrenaic Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.